Fig. 3

Time to Next Line of Therapy^1. Abbreviations: 2 L: second-line; 3 L: third-line. Notes: [1] Time to next line of therapy was defined as the time between the initiation of the first daratumumab-based regimen (index date) and the initiation of the following line of therapy. Patients not initiating a subsequent line of therapy were censored at the end of follow-up